Harp Diagnostics News
2 articles
growth-positive
הכירו את חמשת העולים לגמר פרס אספר 2025 | ASPER HUJI Innovate מרכז החדשנות והיזמות
The article highlights the achievements of five innovative startups that have reached the final stage of the Asper Prize competition. Among them is CardioVia, an Israeli company developing a minimally invasive platform for advanced cardiac treatments. Their first product, ViaOne, has been recognized as a Breakthrough Device by the FDA, paving the way for new cardiac therapies. The competitions final will take place next month at the Hebrew Universitys Safra Campus, where the startups will compete for the title of Rising Startup of the Year 2025 and a grant of 100,000 ILS. The event is supported by the Asper Foundation and hosted by Goldfarb Gross Seligman law firm.
Product StageFDA approved/pending approval
growth-positive
Harp Diagnostics wins IBD Innovate Conference Shark Tank competition | Crohn's & Colitis Foundation
Harp Diagnostics emerged as the winner of the IBD Innovate Conference Shark Tank competition, recognized for its innovative remote rapid monitoring platform designed for managing inflammatory bowel disease (IBD) at home and in office settings. The IBD Innovate conference was a two-day event that gathered leading experts in biotechnology to showcase advancements in therapies, diagnostic devices, and digital health solutions for IBD. The recognition at this event highlights Harp Diagnostics contribution to the field and positions them as a key player in the development of IBD management solutions.
